Physician profile
David Schuller Risner
NPI 1457587099
$2,834.76
in general payments reported to CMS, 2019-2025
22 companies · $1,048 in 2025
The $1,048 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $69.38 · 2021: $331 · 2022: $196 · 2023: $261 · 2024: $487 · 2025: $1,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,795.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $602.54 | 2019-2025 | Argos, Clareon, Rocklatan |
| Ocular Therapeutix, INC. | $246.54 | 2022-2025 | Dextenza |
| Oyster Point Pharma, INC. | $233.98 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Carl Zeiss Meditec USA, INC. | $229.17 | 2021 | |
| Bausch & Lomb Americas INC. | $218.14 | 2022-2025 | Vyzulta, Miebo |
| Abbvie INC. | $210.49 | 2023-2025 | Alphagan P, Lumigan, Vuity |
| Harrow Eye, LLC | $188.51 | 2025 | Vevye |
| Glaukos Corporation | $186.25 | 2022-2025 | |
| Lensar, INC. | $169.30 | 2025 | Lensar Laser System |
| Novartis Pharmaceuticals Corporation | $141.78 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $92.69 | 2019-2022 | |
| Rxsight INC | $76.90 | 2021-2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.38 | 2019-2020 | |
| Amgen INC. | $33.77 | 2025 | Tepezza |
| Biotissue Holdings INC. | $24.95 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $24.79 | 2024 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $22.19 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $21.73 | 2019 | |
| Rayner Intraocular Lenses Limited | $18.64 | 2023 | Rayone Emv, Omidria, Rayone Aspheric |
| New World Medical,INC. | $14.94 | 2023 | |
| Allergan, INC. | $14.16 | 2020 | |
| Sun Pharmaceutical Industries INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Risner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.